Loading the company…
Loading the company…
Families: Peripheral nerve stimulation & intrathecal pumps.
All companies · Product and company coverage
In the last ten years FDA made 1 decision for Nalu Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2019 (1). The latest was on 2019-09-06.
| Family | Decisions on record |
|---|---|
| Peripheral nerve stimulation & intrathecal pumps | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2019-09-06 | 510(k) | K191435 | IPG, integrated, 25/40 cm, single, tined, IPG, 2 cm, single 4, Lead (25/40 cm, 4, tined), Extension - 4 |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Nalu Medical.
In 2025, Nalu Medical reported engagement with 2,345 surgeons and other clinicians in the states MedaRep covers, worth $884K in consulting, speaking, meals and travel for its device products, the most in Arizona ($181K to 235). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Arizona ($181K, 235 engaged), Texas ($147K, 394 engaged), Michigan ($83K, 79 engaged), California ($79K, 274 engaged), Oregon ($73K, 42 engaged).